Sanoculis Ltd: Clinical Trials

11 trials sponsored by Sanoculis Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 terminated, 1 unknown. 8 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 7, Unknown 1

Follow Sanoculis Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MINT® Procedure in Open Angle Glaucoma Eyes.
MINT Minimally Invasive Nasal Trabeculostomy - Glaucoma, Ocular Hypertension
Not applicableCompletedSanoculis Ltd472025-06-162026-10-15
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Minimally Invasive Micro Sclerostomy Device - Primary Open Angle Glaucoma, Open Angle Glaucoma
Not applicableUnknownSanoculis Ltd1292024-06-012024-08-07
MIMS® Retrospective Chart Review
Minimally Invasive Micro Sclerostomy - Open Angle Glaucoma
CompletedSanoculis Ltd342023-09-272026-10-15
Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
Inferonasal Minimally Invasive Micro Sclerostomy - Open Angle Glaucoma
TerminatedSanoculis Ltd442022-11-042026-10-15
Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study
Minimally Invasive Micro Trabeculostomy - Open Angle Glaucoma
CompletedSanoculis Ltd362022-11-042025-01-10
The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP): The Minimally Invasive Micro Sclerostomy (MIMS®) System is Intended for the Reduction of Elevated Intraocular Pressure (IOP)
MIMS - Glaucoma
Not applicableCompletedSanoculis Ltd882022-04-112025-07-04
Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study
MIMS - This Study is Conducted Under Inclusion/ Exclusion Criteria
Not applicableCompletedSanoculis Ltd832022-04-112024-03-12
Minimally Invasive Nasal Trabeculostomy - Performance and Safety Evaluation Study
MINT - This Study is Obtained Under Inclusion/ Exclusion Criteria
Not applicableCompletedSanoculis Ltd712022-04-112024-03-12
Minimally Invasive Micro Sclerostomy: Performance and Safety Evaluation Study
Minimally Invasive Micro Sclerostomy (MIMS) - Glaucoma
Not applicableCompletedSanoculis Ltd1202019-05-292022-11-30
Minimally Invasive Micro Sclerostomy: Safety and Preliminary Performance Study
Minimally Invasive Micro Sclerostomy (MIMS) - Glaucoma
Not applicableCompletedSanoculis Ltd312018-07-162022-11-30
Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study
Minimally Invasive Micro Sclerostomy - Primary Open Angle Glaucoma, Pigmentary Glaucoma
Not applicableCompletedSanoculis Ltd962015-02-012022-11-30

Conditions studied

Glaucoma, Open-Angle (6)  ·  Glaucoma (4)  ·  Ocular Hypertension (1)

Countries

Armenia (8)  ·  India (1)  ·  Israel (1)  ·  United States (1)

Top investigators

Daniel Cotlear, MD (1)

Results publications

PMID 34731867, PMID 38494493, PMID 41446893